Solidarity Fridays - Week 14
Release Date: 07/03/2020
In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...info_outline Ash - CBD, Nootropics, and Micro1p
In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective. Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...info_outline Solidarity Fridays - Week 24
In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....info_outline Wade Davis - Ayahuasca and a New Hope for Colombia
In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th. Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...info_outline Solidarity Fridays - Week 23
In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...info_outline Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens
In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...info_outline Solidarity Fridays - Week 22
In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...info_outline Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity
In this episode, Joe interviews Dr. LaMisha Hill, licensed Counseling Psychologist, board member of the Alameda County Psychological Association, and Director of Multicultural Affairs for the Office of Diversity and Outreach at the University of California, San Francisco. Hill talks about how race and gender of underrepresented people come into play in the psychedelic sphere- in studies, professions, and even in people's consideration of psychedelics as a possible healer for them: how most psychology follows the same well-worn, Euro-centric, fairly western, mostly-for-well-off-college-students...info_outline Solidarity Fridays - Week 21
In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news, including the passing of Tav Sparks; author, therapist, co-director of Grof Transpersonal Training, and creator of "Movie Yoga," and scientist Jordi Riba; one of the early pioneers of ayahuasca research and one of the first ever to bring it into the lab. They discuss the ayahuasca episode of the new Netflix docuseries "Unwell," and 2 articles from Marijuana Moment: psychedelic activists in Oakland creating a guideline for plant medicine healing ceremonies and the new initiative to allow for...info_outline Jerry and Julie Brown - Healing Through Mystical Experience
In this episode, Joe interviews Jerry and Julie Brown. Jerry (Ph.D.) is an author and activist, who served as founding professor of anthropology at Florida International University in Miami for 42 years. Julie (M.A.) is an author and integrative psychotherapist, who worked with cancer patients with a focus on guided imagery. Together, they are co-authors of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity. They talk about their on Psychedelics Today and inspiring studies: Walter Pahnke’s original psilocybin study at Marsh Chapel and Roland Griffiths’...info_outline
In today’s Solidarity Fridays episode, Joe and Kyle sit down and talk about various topics in the news.
They first discuss the duality of how Covid-19 affects different people, and how much of a privilege it is to be able to reconnect with family in new ways and use this time to grow spiritually while so many are out of work and struggling to get by.
They discuss a recent tweet from @Shroomstreet concerning psychedelic stocks and the money being invested in this emerging market, and concerns that some of these unknown companies could be fake or following the “exit scam” model of holding onto investor money and then closing up shop. How many of these companies are in it for the right reasons, and what does this all mean on a grand scale?
They talk about recent reports of psychedelic retreats in excess of $10,000 and the various aspects surrounding these prices, from the cost of education and the need for physicians and therapists to make a living while helping others, to the idea of “pay what you can” and taking a hit financially if it means helping the local community or those really in need without the finances to be able to participate in these retreats. Is pastoral counseling or group therapy the best way to help the most people?
And lastly, they talk about Oregon’s progress in getting legal psilocybin therapy on the ballot in November and the benefits of legality, most importantly towards the ability to report abusive sitters under a framework that would completely remove them from this field.
“The Newtonian-Cartesian paradigm is just so focused on the how- on the mechanics of ‘how does a psychedelic work? Oh, ok, it can treat this. How does it treat this?’ vs. thinking about the idea of final cause and thinking about the why- why do these things exist? What is its purpose, and what is the potential implication here, on a bigger level, than just thinking about this how and thinking ‘this thing does this thing and that’s all we’re really worried about,’ not thinking about that overarching why- like, what is the purpose here?” -Kyle
“I think everybody really should be able to access healing eventually. I think people shouldn’t be starving to death either, but people are still starving to death. I remember Kwasi (Adusei, in Solidarity Fridays week 10) at one point was like, ‘should we bring psychedelics to minority communities for healing?’ Well, why not bring regular mental health services first? Let’s start with clean water, as opposed to ‘let’s give them a road that they didn’t want.’ What’s the cheapest, lowest-hanging fruit that’s going to give the best reward?” -Joe
“Education programs probably would be really helpful. And I think that’s how we fit in. It’s a philosophy thing that could be helpful for both recreationalists and people providing therapeutic experiences, and the experiencers themselves too. It helps to have some education before you go to see God.” -Joe
“I think states should be experimenting with different ways of going forward. Yes, I want everything to be decriminalized- I want everything to be legal, really- personally. I don’t think therapeutic use should be the only use-case. But it’s certainly a lot better than what we’ve got now.” -Joe
Support the show
- Leave us a review on Facebook or iTunes
- Share us with your friends
- Join our Facebook group - Psychedelics Today group – Find the others and create community.